Telesis Bio Inc. financial data

Symbol
TBIO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
10431 Wateridge Circle, Suite 150, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Codex DNA, Inc. (to 10/28/2022)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 253 % -45.3%
Quick Ratio 27.1 % +23%
Debt-to-equity -1.71K % -1655%
Return On Equity 1.84K %
Return On Assets -68 % -59.2%
Operating Margin -251 % -97%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.77M shares -94.1%
Common Stock, Shares, Outstanding 1.77M shares -94.1%
Entity Public Float 14.2M USD -15.5%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.73M shares +4.6%
Weighted Average Number of Shares Outstanding, Diluted 1.73M shares +4.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 19.2M USD -34.9%
Cost of Revenue 10.1M USD -7.58%
Research and Development Expense 13.8M USD -28%
Selling and Marketing Expense 9.89M USD -35.2%
General and Administrative Expense 21.1M USD -2.37%
Operating Income (Loss) -48.1M USD -28.2%
Nonoperating Income (Expense) -882K USD +49.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -49M USD -24.7%
Income Tax Expense (Benefit) 20K USD +5.26%
Net Income (Loss) Attributable to Parent -49.5M USD -24.3%
Earnings Per Share, Basic -2.93 USD/shares +76.7%
Earnings Per Share, Diluted -2.93 USD/shares +76.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.4M USD -86.3%
Accounts Receivable, after Allowance for Credit Loss, Current 1.33M USD -83.8%
Inventory, Net 1.36M USD -64.9%
Assets, Current 15.2M USD -75.4%
Operating Lease, Right-of-Use Asset 26.6M USD -4.86%
Intangible Assets, Net (Excluding Goodwill) 750K USD -53.8%
Goodwill 3.5M USD -76.5%
Assets 52.7M USD -54%
Accounts Payable, Current 1.54M USD +7.41%
Employee-related Liabilities, Current 2.56M USD -32.4%
Contract with Customer, Liability, Current 380K USD -82.5%
Liabilities, Current 8.01M USD -22.8%
Contract with Customer, Liability, Noncurrent 99K USD -33.6%
Operating Lease, Liability, Noncurrent 28.4M USD +2.04%
Liabilities 42.8M USD -26.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9K USD
Retained Earnings (Accumulated Deficit) -183M USD -37.2%
Stockholders' Equity Attributable to Parent -20.5M USD -174%
Liabilities and Equity 52.7M USD -54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.24M USD +71%
Net Cash Provided by (Used in) Financing Activities -27K USD -50%
Net Cash Provided by (Used in) Investing Activities 12.2M USD +197%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.77M shares -94.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.98M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.5M USD -86.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 162K USD -68.2%
Deferred Tax Assets, Valuation Allowance 41.8M USD +42.1%
Deferred Tax Assets, Gross 49.1M USD +61%
Operating Lease, Liability 30.1M USD +2.47%
Depreciation 2.02M USD +41.7%
Payments to Acquire Property, Plant, and Equipment 502K USD +6.81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -49.5M USD -24.4%
Lessee, Operating Lease, Liability, to be Paid 45.8M USD -0.77%
Operating Lease, Liability, Current 1.68M USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.71M USD +1.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.57M USD +6.13%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.8M USD -6.41%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.85M USD +9.31%
Deferred Tax Assets, Operating Loss Carryforwards 28.7M USD +15.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 338K USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.99M USD +9.33%
Operating Lease, Payments 548K USD +18.9%
Additional Paid in Capital 162M USD +0.69%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 515K USD -2.83%
Deferred Tax Assets, Net of Valuation Allowance 7.31M USD +580%
Share-based Payment Arrangement, Expense 3.41M USD -22.6%
Interest Expense 214K USD -69.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares